Literature DB >> 11689668

Recombinant Newcastle disease virus as a vaccine vector.

T Nakaya1, J Cros, M S Park, Y Nakaya, H Zheng, A Sagrera, E Villar, A García-Sastre, P Palese.   

Abstract

A complete cDNA clone of the Newcastle disease virus (NDV) vaccine strain Hitchner B1 was constructed, and infectious recombinant virus expressing an influenza virus hemagglutinin was generated by reverse genetics. The rescued virus induces a strong humoral antibody response against influenza virus and provides complete protection against a lethal dose of influenza virus challenge in mice, demonstrating the potential of recombinant NDV as a vaccine vector.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11689668      PMCID： PMC114773          DOI： 10.1128/JVI.75.23.11868-11873.2001

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  37 in total

1.  High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses.

Authors:  E Kretzschmar; L Buonocore; M J Schnell; J K Rose
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine.

Authors:  R R Deck; C M DeWitt; J J Donnelly; M A Liu; J B Ulmer
Journal:  Vaccine       Date:  1997-01       Impact factor: 3.641

Review 3.  Immunization with virus-modified tumor cells.

Authors:  V Schirrmacher; T Ahlert; T Pröbstle; H H Steiner; C Herold-Mende; R Gerhards; E Hagmüller; H H Steiner
Journal:  Semin Oncol       Date:  1998-12       Impact factor: 4.929

Review 4.  Recovery of negative-strand RNA viruses from plasmid DNAs: a positive approach revitalizes a negative field.

Authors:  A Roberts; J K Rose
Journal:  Virology       Date:  1998-07-20       Impact factor: 3.616

Review 5.  Negative-strand RNA viruses: applications to biotechnology.

Authors:  A García-Sastre
Journal:  Trends Biotechnol       Date:  1998-05       Impact factor: 19.536

6.  Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection.

Authors:  M J Schnell; J E Johnson; L Buonocore; J K Rose
Journal:  Cell       Date:  1997-09-05       Impact factor: 41.582

7.  Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge.

Authors:  A Roberts; E Kretzschmar; A S Perkins; J Forman; R Price; L Buonocore; Y Kawaoka; J K Rose
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice.

Authors:  P R Grigera; M P Marzocca; A V Capozzo; L Buonocore; R O Donis; J K Rose
Journal:  Virus Res       Date:  2000-08       Impact factor: 3.303

9.  Chimeric measles viruses with a foreign envelope.

Authors:  P Spielhofer; T Bächi; T Fehr; G Christiansen; R Cattaneo; K Kaelin; M A Billeter; H Y Naim
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

10.  A plasmid-based reverse genetics system for influenza A virus.

Authors:  S Pleschka; R Jaskunas; O G Engelhardt; T Zürcher; P Palese; A García-Sastre
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103
View more
  112 in total

1.  Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.

Authors:  Jinying Ge; Xijun Wang; Lihong Tao; Zhiyuan Wen; Na Feng; Songtao Yang; Xianzhu Xia; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  A majority of infectious Newcastle disease virus particles contain a single genome, while a minority contain multiple genomes.

Authors:  Peter H Goff; Qinshan Gao; Peter Palese
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

3.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

Review 4.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

5.  Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus.

Authors:  Masaki Mibayashi; Luis Martínez-Sobrido; Yueh-Ming Loo; Washington B Cárdenas; Michael Gale; Adolfo García-Sastre
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

6.  Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models.

Authors:  Sara Cuadrado-Castano; Juan Ayllon; Mena Mansour; Janis de la Iglesia-Vicente; Stefan Jordan; Shashank Tripathi; Adolfo García-Sastre; Enrique Villar
Journal:  Mol Cancer Ther       Date:  2015-03-11       Impact factor: 6.261

7.  Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein.

Authors:  Shin-Hee Kim; Siba K Samal
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

8.  A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

Authors:  Zhuhui Huang; Subbiah Elankumaran; Abdul S Yunus; Siba K Samal
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Mutations in the ectodomain of newcastle disease virus fusion protein confer a hemagglutinin-neuraminidase-independent phenotype.

Authors:  Juan Ayllón; Enrique Villar; Isabel Muñoz-Barroso
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

10.  Detection of free peritoneal cancer cells in gastric cancer using cancer-specific Newcastle disease virus.

Authors:  Joyce Wong; Allison Schulman; Kaitlyn Kelly; Dmitriy Zamarin; Peter Palese; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2009-11-10       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.